To evaluate the anti-tumour activity of RMC-7977 in clinically predictive models of human PDAC, we first performed an interventional survival study in tumour-bearing KrasLSL.G12D/+;Trp53LSL.R172H/+;Pdx1-cretg/+ (KPC) mice. The gene discussed is PDX1; the disease is neoplasm.